Table of Content

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview
Overview
Technology Background
Omics Types
Various Multiomics Approaches and Applications
Technological Infrastructure and Data Integration
PESTEL Analysis
Political
Economic
Social
Technological
Environmental
Legal
Regulatory Landscape
Federal Regulation
CMS Regulation
U.S. Food and Drug Administration Regulation
U.S. Federal Trade Commission Regulation
Strategic Recommendations

Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Rapid Advances in Multiomics Research and its Applications
Favorable Funding Scenario for Multiomics Research Activities
Decrease in DNA-Sequencing Method Prices
Growing Prevalence of Cancer Generating Demand for Personalized Treatments
Promising Applications of Multiomics in the Drug Development Process
Market Restraints
Lack of Data Standardization
Market Opportunities
Expanding Single-Cell Multiomics Applications

Chapter 4 Emerging Technologies and Developments
Artificial Intelligence in Multiomics
Companies in the Artificial Intelligence Multiomics Market
Advances in Single-Cell Omics and Multiomics

Chapter 5 Market Segmentation Analysis
Key Market Trends
Segmentation Breakdown
Global Market for Multiomics by Product
Instruments
Consumables
Software and Services
Global Market for Multiomics by Platform
Genomics
Proteomics
Transcriptomics
Metabolomics
Other Platforms
Global Market for Multiomics by Application
Oncology
Immunology
Neurology
Cell Biology
Other Applications
Global Market for Multiomics by End User
Academic Research Organizations
Pharmaceutical and Biotechnology Companies
Clinical and Hospital Laboratories
Other End Users
Geographic Breakdown
Global Multiomics Market by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence
Top Players Ranking
Key Strategies Adopted by Players
Collaborations and Partnerships
New Product Launches
Expansions and Investments
Mergers and Acquisitions
Agreements
Patent Analysis

Chapter 7 Sustainability in Multiomics Market: ESG Perspective
Introduction to ESG
ESG Performance in Market
ESG Practices in the Multiomics Industry

Chapter 8 Appendix
Methodology
Acronyms
References
Company Profiles
AGILENT TECHNOLOGIES INC.
BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
BIO-RAD LABORATORIES INC.
BD
BRUKER
BGI
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
QIAGEN
REVVITY
STANDARD BIOTOOLS
THERMO FISHER SCIENTIFIC INC.



List of Figures


Summary Figure A : Global Market for Multiomics, by Product, 2021–2029
Summary Figure B : Global Market for Multiomics, by Region, 2021–2029
Figure 1 : Omics Types
Figure 2 : Applications of Multiomics Approaches
Figure 3 : PESTEL Analysis: Multiomics Market
Figure 4 : Strategic Recommendations: Multiomics Market
Figure 5 : Multiomics Market Dynamics
Figure 6 : Average Cost Per Genome: Year-on-Year Trend, 2011–2022
Figure 7 : Global Market Shares for Multiomics, by Product, 2024
Figure 8 : Global Market for Multiomics for Instruments, by Region, 2021–2029
Figure 9 : Global Market for Multiomics for Consumables, by Region, 2021–2029
Figure 10 : Global Market for Multiomics for Software and Services, by Region, 2021–2029
Figure 11 : Global Market Shares for Multiomics, by Platform, 2024
Figure 12 : Global Market for Multiomics for Genomics, by Region, 2021–2029
Figure 13 : Global Market for Multiomics for Proteomics, by Region, 2021–2029
Figure 14 : Global Market for Multiomics for Transcriptomics, by Region, 2021–2029
Figure 15 : Global Market for Multiomics for Metabolomics, by Region, 2021–2029
Figure 16 : Global Market for Multiomics for Other Platforms, by Region, 2021–2029
Figure 17 : Major Applications of Multiomics
Figure 18 : Global Market Shares for Multiomics, by Application, 2024
Figure 19 : Global Market for Multiomics for Oncology, by Region, 2021–2029
Figure 20 : Global Market for Multiomics for Immunology, by Region, 2021–2029
Figure 21 : Global Market for Multiomics for Neurology, by Region, 2021–2029
Figure 22 : Global Market for Multiomics for Cell Biology, by Region, 2021–2029
Figure 23 : Global Market for Multiomics for Other Applications, by Region, 2021–2029
Figure 24 : Global Market Shares for Multiomics, by End User, 2024
Figure 25 : Global Market for Multiomics for Academic Research Organizations, by Region, 2021?-2029
Figure 26 : Global Market for Multiomics for Pharmaceutical and Biotechnology Companies, by Region, 2021–2029
Figure 27 : Global Market for Multiomics for Clinical and Hospital Laboratories, by Region, 2021–2029
Figure 28 : Global Market for Multiomics for Other End Users, by Region, 2021–2029
Figure 29 : Global Market Shares of Multiomics, by Region, 2024
Figure 30 : North American Market for Multiomics, by Product, 2021–2029
Figure 31 : North American Market for Multiomics, by Platform, 2021–2029
Figure 32 : North American Market for Multiomics, by Application, 2021–2029
Figure 33 : North American Market for Multiomics, by End User, 2021–2029
Figure 34 : European Market for Multiomics, by Product, 2021–2029
Figure 35 : European Market for Multiomics, by Platform, 2021–2029
Figure 36 : European Market for Multiomics, by Application, 2021–2029
Figure 37 : European Market for Multiomics, by End User, 2021–2029
Figure 38 : Asia-Pacific Multiomics Market Growth Drivers
Figure 39 : Asia-Pacific Market for Multiomics, by Product, 2021–2029
Figure 40 : Asia-Pacific Market for Multiomics, by Platform, 2021–2029
Figure 41 : Asia-Pacific Market for Multiomics, by Application, 2021–2029
Figure 42 : Asia-Pacific Market for Multiomics, by End User, 2021–2029
Figure 43 : Rest of the World Market for Multiomics, by Product, 2021–2029
Figure 44 : Rest of the World Market for Multiomics, by Platform, 2021–2029
Figure 45 : Rest of the World Market for Multiomics, by Application, 2021–2029
Figure 46 : Rest of the World Market for Multiomics, by End User, 2021–2029
Figure 47 : Global Multiomics Market Competitive Intelligence, 2020–2024
Figure 48 : Patents, 2018–2023
Figure 49 : How a Strong ESG Proposition Benefits Businesses
Figure 50 : Biotech Companies Providing ESG Disclosure, 2022
Figure 51 : Location of ESG Disclosure, 2022
Figure 52 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 53 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 54 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 55 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 56 : BD: Revenue Share, by Business Unit, FY 2023
Figure 57 : BD: Revenue Share, by Country/Region, FY 2023
Figure 58 : Bruker: Revenue Share, by Business Unit, FY 2023
Figure 59 : Bruker: Revenue Share, by Country/Region, FY 2023
Figure 60 : F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 61 : F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 62 : Illumina Inc.: Revenue Share, by Business Unit, FY 2023
Figure 63 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 64 : QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 65 : QIAGEN: Revenue Share, by Country/Region, FY 2023
Figure 66 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 67 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 68 : Standard BioTools: Revenue Share, by Business Unit, FY 2023
Figure 69 : Standard BioTools: Revenue Share, by Country/Region, FY 2023
Figure 70 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 71 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023

List of Tables


Summary Table A : Global Market for Multiomics, by Product, Through 2029
Summary Table B : Global Market for Multiomics, by Region, Through 2029
Table 1 : Multiomics Approaches and Their Molecular Readouts
Table 2 : Molecular Biology Technologies for Multiomics Approaches
Table 3 : Single-Cell and Spatial Omics Technologies, 2018–2023
Table 4 : Publicly Available Omics Data in the Cancer Research Field
Table 5 : Multiomics’ Role During Various Stages of Drug Development Process
Table 6 : Companies in the Artificial Intelligence Multiomics Market
Table 7 : Global Market for Multiomics, by Product, Through 2029
Table 8 : Global Market for Multiomics for Instruments, by Region, Through 2029
Table 9 : Global Market for Multiomics for Consumables, by Region, Through 2029
Table 10 : Global Market for Multiomics for Software and Services, by Region, Through 2029
Table 11 : Global Market for Multiomics, by Platform, Through 2029
Table 12 : Global Market for Multiomics for Genomics, by Region, Through 2029
Table 13 : Global Market for Multiomics for Proteomics, by Region, Through 2029
Table 14 : Global Market for Multiomics for Transcriptomics, by Region, Through 2029
Table 15 : Global Market for Multiomics for Metabolomics, by Region, Through 2029
Table 16 : Global Market for Multiomics for Other Platforms, by Region, Through 2029
Table 17 : Global Market for Multiomics, by Application, Through 2029
Table 18 : Global Market for Multiomics for Oncology, by Region, Through 2029
Table 19 : Global Market for Multiomics for Immunology, by Region, Through 2029
Table 20 : Global Market for Multiomics for Neurology, by Region, Through 2029
Table 21 : Global Market for Multiomics for Cell Biology, by Region, Through 2029
Table 22 : Global Market for Multiomics for Other Applications, by Region, Through 2029
Table 23 : Global Market for Multiomics, by End User, Through 2029
Table 24 : Global Market for Multiomics for Academic Research Organizations, by Region, Through 2029
Table 25 : Global Market for Multiomics for Pharmaceutical and Biotechnology Companies, by Region, Through 2029
Table 26 : Global Market for Multiomics for Clinical and Hospital Laboratories, by Region, Through 2029
Table 27 : Global Market for Multiomics for Other End Users, by Region, Through 2029
Table 28 : Global Market for Multiomics, by Region, Through 2029
Table 29 : North American Market for Multiomics, by Product, Through 2029
Table 30 : North American Market for Multiomics, by Platform, Through 2029
Table 31 : North American Market for Multiomics, by Application, Through 2029
Table 32 : North American Market for Multiomics, by End User, Through 2029
Table 33 : European Initiatives Focused on Omics Research for Personalized Medicine
Table 34 : European Market for Multiomics, by Product, Through 2029
Table 35 : European Market for Multiomics, by Platform, Through 2029
Table 36 : European Market for Multiomics, by Application, Through 2029
Table 37 : European Market for Multiomics, by End User, Through 2029
Table 38 : Asia-Pacific Market for Multiomics, by Product, Through 2029
Table 39 : Asia-Pacific Market for Multiomics, by Platform, Through 2029
Table 40 : Asia-Pacific Market for Multiomics, by Application, Through 2029
Table 41 : Asia-Pacific Market for Multiomics, by End User, Through 2029
Table 42 : Rest of the World Market for Multiomics, by Product, Through 2029
Table 43 : Rest of the World Market for Multiomics, by Platform, Through 2029
Table 44 : Rest of the World Market for Multiomics, by Application, Through 2029
Table 45 : Rest of the World Market for Multiomics, by End User, Through 2029
Table 46 : Top Players in Multiomics Market, 2023
Table 47 : Collaborations and Partnerships: Multiomics Market, 2021-2024
Table 48 : New Product Launches: Multiomics Market, 2021–2024
Table 49 : Expansions and Investments: Multiomics Market, 2021–2024
Table 50 : Mergers and Acquisitions: Multiomics Market, 2020-2024
Table 51 : Agreements: Multiomics Market, 2022-2024
Table 52 : Multiomics Market: Patent Analysis, 2018–2023
Table 53 : Key Focus Areas in ESG Metrics
Table 54 : Environmental Performance Initiatives in the Multiomics Market, 2022 and 2023
Table 55 : Social Performance Initiatives in the Multiomics Market, 2022 and 2023
Table 56 : Governance Performance Initiatives in the Multiomics Market, 2022 and 2023
Table 57 : ESG Rankings for Multiomics Companies, 2024*
Table 58 : Acronyms Used in this Report
Table 59 : Agilent Technologies Inc.: Company Snapshot
Table 60 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 61 : Agilent Technologies Inc.: Product Portfolio
Table 62 : Agilent Technologies Inc.: News/Key Developments, 2023
Table 63 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Company Snapshot
Table 64 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Product Portfolio
Table 65 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): News/Key Developments, 2023
Table 66 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 67 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 68 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 69 : Bio-Rad Laboratories Inc.: News/Key Developments, 2020
Table 70 : BD: Company Snapshot
Table 71 : BD: Financial Performance, FY 2022 and 2023
Table 72 : BD: Product Portfolio
Table 73 : BD: News/Key Developments, 2024
Table 74 : Bruker: Company Snapshot
Table 75 : Bruker: Financial Performance, FY 2022 and 2023
Table 76 : Bruker: Product Portfolio
Table 77 : Bruker: News/Key Developments, 2024
Table 78 : BGI: Company Snapshot
Table 79 : BGI: Product Portfolio
Table 80 : BGI: News/Key Developments, 2024
Table 81 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 82 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 83 : F. Hoffman-La Roche Ltd.: Product Portfolio
Table 84 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2022
Table 85 : Illumina Inc.: Company Snapshot
Table 86 : Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 87 : Illumina Inc.: Product Portfolio
Table 88 : Illumina Inc.: News/Key Developments, 2023
Table 89 : QIAGEN: Company Snapshot
Table 90 : QIAGEN: Financial Performance, FY 2022 and 2023
Table 91 : QIAGEN: Product Portfolio
Table 92 : QIAGEN: News/Key Developments, 2024
Table 93 : Revvity: Company Snapshot
Table 94 : Revvity: Financial Performance, FY 2022 and 2023
Table 95 : Revvity: Product Portfolio
Table 96 : Revvity: News/Key Developments, 2023
Table 97 : Standard BioTools: Company Snapshot
Table 98 : Standard BioTools: Financial Performance, FY 2022 and 2023
Table 99 : Standard BioTools: Product Portfolio
Table 100 : Standard BioTools: News/Key Developments, 2024
Table 101 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 102 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 103 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 104 : Thermo Fisher Scientific Inc.: News/Key Developments, 2024